Subjects with MDS-IB2 had a higher prevalence of mutations in BCOR (15% versus 6%; P = 0.02) and WT1 (7% versus 1%; P = 0.03) compared with subjects with MDS-IB1. Here, BCOR is linked to myelodysplastic syndrome.